Table 3 Incidence and characteristics of acute-onset endophthalmitis after 25-gauge pars plana vitrectomy
Study (year) | Present study (2019) | Lihteh et al. [26] | Oshima et al. [2] | Chen et al. [22] | Scott et al. [17] | Shimada et al. [20] | Kunimoto et al. [21] |
|---|---|---|---|---|---|---|---|
Period of study (number of years) | 2005–2017 (13) | 2005–2009 (5) | 2003–2008 (6) | 2002–2006 (5) | 2005–2006 (2) | 2004–2007 (4) | 2004–2006 (3) |
No. of cases per patients (incidence rate) | 2/1089 (0.18) | 1/4717 (0.02) | 6/8238 (0.07) | 1/431 (0.23) | 11/1307 (0.84) | 1/3343 (0.03) | 7/3103 (0.23) |
No. of cases with postoperative hypotony (%) | 0 | NA | 1/6 (17) | 0 | NA | 0 | 0 |
Intraoperative injections (number of infected eyes receiving injections) | 0 | 0 | NA | SC DEX (1/1) | SC cefazolin (9/11) | SC tobramycin and DEX (1/1) | Gentamicin in infusion fluid (7/7) |
Median onset of endophthalmitis (days) | 9 (5–13) | 5 | 2 (1–3) | 7 | 3 (1–15) | 1 | 2 (2–10) |
No. of cases with culture-positive (%) | 0/2 (0) | 0/1 (0) | 3/6 (50) | 0/1 (0) | 7/11 (63) | 1/1 (100) | NA |
Causative Microorganisms (%) | – | – | MRSE (67) | – | CNS (86) | ES | NA |